APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucose-based Peritoneal Dialysis Solution

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Glucose-based Peritoneal Dialysis Solution Market Outlook and Growth Opportunities 2026

8 January 2026195 pages

Choose your research edition.

Industry ResearchGlucose-based Peritoneal Dialysis Solution Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucose-based Peritoneal Dialysis Solution Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Glucose-based Peritoneal Dialysis Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucose-based Peritoneal Dialysis Solution Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucose-based Peritoneal Dialysis Solution Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Glucose-based Peritoneal Dialysis Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Glucose-based Peritoneal Dialysis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glucose-based Peritoneal Dialysis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucose-based Peritoneal Dialysis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Glucose-based Peritoneal Dialysis Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Glucose-based Peritoneal Dialysis Solution market include Baxter, Fresenius, B. Braun, WEGO, Huaren Pharmaceutical, CR Double-Crane, Qingshan Likang, SSY Group and Wuhu Daorun Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glucose-based Peritoneal Dialysis Solution market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glucose-based Peritoneal Dialysis Solution and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glucose-based Peritoneal Dialysis Solution sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glucose-based Peritoneal Dialysis Solution market size, projected growth trends, production technologies, key applications, and end-use industries.

Glucose-based Peritoneal Dialysis Solution Segment by Company

Baxter

Fresenius

B. Braun

WEGO

Huaren Pharmaceutical

CR Double-Crane

Qingshan Likang

SSY Group

Wuhu Daorun Pharmaceuticals

Pharmasyntez Group

Glucose-based Peritoneal Dialysis Solution Segment by Type

Containing 1.5% Glucose

Containing 2.5% Glucose

Containing 4.25% Glucose

Glucose-based Peritoneal Dialysis Solution Segment by Application

Hospital

Clinic

Dialysis Center

Glucose-based Peritoneal Dialysis Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Glucose-based Peritoneal Dialysis Solution status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Glucose-based Peritoneal Dialysis Solution market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Glucose-based Peritoneal Dialysis Solution significant trends, drivers, influence factors in global and regions.

6. To analyze Glucose-based Peritoneal Dialysis Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucose-based Peritoneal Dialysis Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucose-based Peritoneal Dialysis Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucose-based Peritoneal Dialysis Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glucose-based Peritoneal Dialysis Solution market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glucose-based Peritoneal Dialysis Solution industry.

Chapter 3: Detailed analysis of Glucose-based Peritoneal Dialysis Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Glucose-based Peritoneal Dialysis Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Glucose-based Peritoneal Dialysis Solution in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Glucose-based Peritoneal Dialysis Solution Industry Trends Table 2. Glucose-based Peritoneal Dialysis Solution Industry Drivers Table 3. Glucose-based Peritoneal Dialysis Solution Industry Opportunities and Challenges Table 4. Glucose-based Peritoneal Dialysis Solution Industry Restraints Table 5. Global Glucose-based Peritoneal Dialysis Solution Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Glucose-based Peritoneal Dialysis Solution Revenue Share by Company (2021-2026) Table 7. Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Company (k units) & (2021-2026) Table 8. Global Glucose-based Peritoneal Dialysis Solution Sales Volume Share by Company (2021-2026) Table 9. Global Glucose-based Peritoneal Dialysis Solution Average Price (USD/unit) of Company (2021-2026) Table 10. Global Glucose-based Peritoneal Dialysis Solution Company Ranking, (2024-2026) & (USD Million) Table 11. Global Glucose-based Peritoneal Dialysis Solution Key Company Manufacturing Base & Headquarters Table 12. Global Glucose-based Peritoneal Dialysis Solution Company, Product Type & Application Table 13. Global Glucose-based Peritoneal Dialysis Solution Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Glucose-based Peritoneal Dialysis Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Containing 1.5% Glucose Table 18. Significant Companies of Containing 2.5% Glucose Table 19. Significant Companies of Containing 4.25% Glucose Table 20. Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Type (2021-2026) & (k units) Table 22. Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Type (2027-2032) & (k units) Table 23. Global Glucose-based Peritoneal Dialysis Solution Sales Volume Share by Type (2021-2026) Table 24. Global Glucose-based Peritoneal Dialysis Solution Sales Volume Share by Type (2027-2032) Table 25. Global Glucose-based Peritoneal Dialysis Solution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Glucose-based Peritoneal Dialysis Solution Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Glucose-based Peritoneal Dialysis Solution Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type (2021-2026) Table 29. Global Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Dialysis Center Table 33. Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Application (2021-2026) & (k units) Table 35. Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Application (2027-2032) & (k units) Table 36. Global Glucose-based Peritoneal Dialysis Solution Sales Volume Share by Application (2021-2026) Table 37. Global Glucose-based Peritoneal Dialysis Solution Sales Volume Share by Application (2027-2032) Table 38. Global Glucose-based Peritoneal Dialysis Solution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Glucose-based Peritoneal Dialysis Solution Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Glucose-based Peritoneal Dialysis Solution Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application (2021-2026) Table 42. Global Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application (2027-2032) Table 43. Global Glucose-based Peritoneal Dialysis Solution Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Glucose-based Peritoneal Dialysis Solution Sales by Region (2021-2026) & (k units) Table 45. Global Glucose-based Peritoneal Dialysis Solution Sales Market Share by Region (2021-2026) Table 46. Global Glucose-based Peritoneal Dialysis Solution Sales by Region (2027-2032) & (k units) Table 47. Global Glucose-based Peritoneal Dialysis Solution Sales Market Share by Region (2027-2032) Table 48. Global Glucose-based Peritoneal Dialysis Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Glucose-based Peritoneal Dialysis Solution Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Glucose-based Peritoneal Dialysis Solution Sales Value Share by Region (2021-2026) Table 51. Global Glucose-based Peritoneal Dialysis Solution Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Glucose-based Peritoneal Dialysis Solution Sales Value Share by Region (2027-2032) Table 53. Global Glucose-based Peritoneal Dialysis Solution Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Glucose-based Peritoneal Dialysis Solution Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Glucose-based Peritoneal Dialysis Solution Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Glucose-based Peritoneal Dialysis Solution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Glucose-based Peritoneal Dialysis Solution Sales by Country (2021-2026) & (k units) Table 58. Global Glucose-based Peritoneal Dialysis Solution Sales Market Share by Country (2021-2026) Table 59. Global Glucose-based Peritoneal Dialysis Solution Sales by Country (2027-2032) & (k units) Table 60. Global Glucose-based Peritoneal Dialysis Solution Sales Market Share by Country (2027-2032) Table 61. Global Glucose-based Peritoneal Dialysis Solution Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Glucose-based Peritoneal Dialysis Solution Sales Value Market Share by Country (2021-2026) Table 63. Global Glucose-based Peritoneal Dialysis Solution Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Glucose-based Peritoneal Dialysis Solution Sales Value Market Share by Country (2027-2032) Table 65. Baxter Company Information Table 66. Baxter Business Overview Table 67. Baxter Glucose-based Peritoneal Dialysis Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Baxter Glucose-based Peritoneal Dialysis Solution Product Portfolio Table 69. Baxter Recent Development Table 70. Fresenius Company Information Table 71. Fresenius Business Overview Table 72. Fresenius Glucose-based Peritoneal Dialysis Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Fresenius Glucose-based Peritoneal Dialysis Solution Product Portfolio Table 74. Fresenius Recent Development Table 75. B. Braun Company Information Table 76. B. Braun Business Overview Table 77. B. Braun Glucose-based Peritoneal Dialysis Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. B. Braun Glucose-based Peritoneal Dialysis Solution Product Portfolio Table 79. B. Braun Recent Development Table 80. WEGO Company Information Table 81. WEGO Business Overview Table 82. WEGO Glucose-based Peritoneal Dialysis Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. WEGO Glucose-based Peritoneal Dialysis Solution Product Portfolio Table 84. WEGO Recent Development Table 85. Huaren Pharmaceutical Company Information Table 86. Huaren Pharmaceutical Business Overview Table 87. Huaren Pharmaceutical Glucose-based Peritoneal Dialysis Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Huaren Pharmaceutical Glucose-based Peritoneal Dialysis Solution Product Portfolio Table 89. Huaren Pharmaceutical Recent Development Table 90. CR Double-Crane Company Information Table 91. CR Double-Crane Business Overview Table 92. CR Double-Crane Glucose-based Peritoneal Dialysis Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. CR Double-Crane Glucose-based Peritoneal Dialysis Solution Product Portfolio Table 94. CR Double-Crane Recent Development Table 95. Qingshan Likang Company Information Table 96. Qingshan Likang Business Overview Table 97. Qingshan Likang Glucose-based Peritoneal Dialysis Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Qingshan Likang Glucose-based Peritoneal Dialysis Solution Product Portfolio Table 99. Qingshan Likang Recent Development Table 100. SSY Group Company Information Table 101. SSY Group Business Overview Table 102. SSY Group Glucose-based Peritoneal Dialysis Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. SSY Group Glucose-based Peritoneal Dialysis Solution Product Portfolio Table 104. SSY Group Recent Development Table 105. Wuhu Daorun Pharmaceuticals Company Information Table 106. Wuhu Daorun Pharmaceuticals Business Overview Table 107. Wuhu Daorun Pharmaceuticals Glucose-based Peritoneal Dialysis Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Wuhu Daorun Pharmaceuticals Glucose-based Peritoneal Dialysis Solution Product Portfolio Table 109. Wuhu Daorun Pharmaceuticals Recent Development Table 110. Pharmasyntez Group Company Information Table 111. Pharmasyntez Group Business Overview Table 112. Pharmasyntez Group Glucose-based Peritoneal Dialysis Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Pharmasyntez Group Glucose-based Peritoneal Dialysis Solution Product Portfolio Table 114. Pharmasyntez Group Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Glucose-based Peritoneal Dialysis Solution Distributors List Table 118. Glucose-based Peritoneal Dialysis Solution Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Glucose-based Peritoneal Dialysis Solution Product Image Figure 2. Global Glucose-based Peritoneal Dialysis Solution Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucose-based Peritoneal Dialysis Solution Sales Value (2021-2032) & (US$ Million) Figure 4. Global Glucose-based Peritoneal Dialysis Solution Sales (2021-2032) & (k units) Figure 5. Global Glucose-based Peritoneal Dialysis Solution Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Glucose-based Peritoneal Dialysis Solution Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Containing 1.5% Glucose Image Figure 10. Containing 2.5% Glucose Image Figure 11. Containing 4.25% Glucose Image Figure 12. Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Glucose-based Peritoneal Dialysis Solution Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Glucose-based Peritoneal Dialysis Solution Sales Volume Share by Type (2021-2032) Figure 15. Global Glucose-based Peritoneal Dialysis Solution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Glucose-based Peritoneal Dialysis Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Dialysis Center Image Figure 21. Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Glucose-based Peritoneal Dialysis Solution Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Glucose-based Peritoneal Dialysis Solution Sales Volume Share by Application (2021-2032) Figure 24. Global Glucose-based Peritoneal Dialysis Solution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Glucose-based Peritoneal Dialysis Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application (2021-2032) Figure 27. Global Glucose-based Peritoneal Dialysis Solution Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Glucose-based Peritoneal Dialysis Solution Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Glucose-based Peritoneal Dialysis Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Glucose-based Peritoneal Dialysis Solution Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Glucose-based Peritoneal Dialysis Solution Sales Value (2021-2032) & (US$ Million) Figure 32. North America Glucose-based Peritoneal Dialysis Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Glucose-based Peritoneal Dialysis Solution Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Glucose-based Peritoneal Dialysis Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Glucose-based Peritoneal Dialysis Solution Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Glucose-based Peritoneal Dialysis Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Glucose-based Peritoneal Dialysis Solution Sales Value (2021-2032) & (US$ Million) Figure 38. South America Glucose-based Peritoneal Dialysis Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Glucose-based Peritoneal Dialysis Solution Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Glucose-based Peritoneal Dialysis Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Glucose-based Peritoneal Dialysis Solution Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Glucose-based Peritoneal Dialysis Solution Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Containing 1.5% Glucose
  • Containing 2.5% Glucose
  • Containing 4.25% Glucose
Applications
  • Hospital
  • Clinic
  • Dialysis Center
Companies covered
  • Baxter
  • Fresenius
  • B. Braun
  • WEGO
  • Huaren Pharmaceutical
  • CR Double-Crane
  • Qingshan Likang
  • SSY Group
  • Wuhu Daorun Pharmaceuticals
  • Pharmasyntez Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glucose-based Peritoneal Dialysis Solution Sales Value (2021-2032)
  4. 1.2.2 Global Glucose-based Peritoneal Dialysis Solution Sales Volume (2021-2032)
  5. 1.2.3 Global Glucose-based Peritoneal Dialysis Solution Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Glucose-based Peritoneal Dialysis Solution Market Dynamics
  1. 2.1 Glucose-based Peritoneal Dialysis Solution Industry Trends
  2. 2.2 Glucose-based Peritoneal Dialysis Solution Industry Drivers
  3. 2.3 Glucose-based Peritoneal Dialysis Solution Industry Opportunities and Challenges
  4. 2.4 Glucose-based Peritoneal Dialysis Solution Industry Restraints
3 Glucose-based Peritoneal Dialysis Solution Market by Company
  1. 3.1 Global Glucose-based Peritoneal Dialysis Solution Company Revenue Ranking in 2025
  2. 3.2 Global Glucose-based Peritoneal Dialysis Solution Revenue by Company (2021-2026)
  3. 3.3 Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Company (2021-2026)
  4. 3.4 Global Glucose-based Peritoneal Dialysis Solution Average Price by Company (2021-2026)
  5. 3.5 Global Glucose-based Peritoneal Dialysis Solution Company Ranking (2024-2026)
  6. 3.6 Global Glucose-based Peritoneal Dialysis Solution Company Manufacturing Base and Headquarters
  7. 3.7 Global Glucose-based Peritoneal Dialysis Solution Company Product Type and Application
  8. 3.8 Global Glucose-based Peritoneal Dialysis Solution Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Glucose-based Peritoneal Dialysis Solution Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Glucose-based Peritoneal Dialysis Solution Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Glucose-based Peritoneal Dialysis Solution Market by Type
  1. 4.1 Glucose-based Peritoneal Dialysis Solution Type Introduction
  2. 4.1.1 Containing 1.5% Glucose
  3. 4.1.2 Containing 2.5% Glucose
  4. 4.1.3 Containing 4.25% Glucose
  5. 4.2 Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Type
  6. 4.2.1 Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Glucose-based Peritoneal Dialysis Solution Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Glucose-based Peritoneal Dialysis Solution Sales Value by Type
  10. 4.3.1 Global Glucose-based Peritoneal Dialysis Solution Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Glucose-based Peritoneal Dialysis Solution Sales Value by Type (2021-2032)
  12. 4.3.3 Global Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type (2021-2032)
5 Glucose-based Peritoneal Dialysis Solution Market by Application
  1. 5.1 Glucose-based Peritoneal Dialysis Solution Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Dialysis Center
  5. 5.2 Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Application
  6. 5.2.1 Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Glucose-based Peritoneal Dialysis Solution Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Glucose-based Peritoneal Dialysis Solution Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Glucose-based Peritoneal Dialysis Solution Sales Value by Application
  10. 5.3.1 Global Glucose-based Peritoneal Dialysis Solution Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Glucose-based Peritoneal Dialysis Solution Sales Value by Application (2021-2032)
  12. 5.3.3 Global Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application (2021-2032)
6 Glucose-based Peritoneal Dialysis Solution Regional Sales and Value Analysis
  1. 6.1 Global Glucose-based Peritoneal Dialysis Solution Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glucose-based Peritoneal Dialysis Solution Sales by Region (2021-2032)
  3. 6.2.1 Global Glucose-based Peritoneal Dialysis Solution Sales by Region: 2021-2026
  4. 6.2.2 Global Glucose-based Peritoneal Dialysis Solution Sales by Region (2027-2032)
  5. 6.3 Global Glucose-based Peritoneal Dialysis Solution Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Glucose-based Peritoneal Dialysis Solution Sales Value by Region (2021-2032)
  7. 6.4.1 Global Glucose-based Peritoneal Dialysis Solution Sales Value by Region: 2021-2026
  8. 6.4.2 Global Glucose-based Peritoneal Dialysis Solution Sales Value by Region (2027-2032)
  9. 6.5 Global Glucose-based Peritoneal Dialysis Solution Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Glucose-based Peritoneal Dialysis Solution Sales Value (2021-2032)
  12. 6.6.2 North America Glucose-based Peritoneal Dialysis Solution Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Glucose-based Peritoneal Dialysis Solution Sales Value (2021-2032)
  15. 6.7.2 Europe Glucose-based Peritoneal Dialysis Solution Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Glucose-based Peritoneal Dialysis Solution Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Glucose-based Peritoneal Dialysis Solution Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Glucose-based Peritoneal Dialysis Solution Sales Value (2021-2032)
  21. 6.9.2 South America Glucose-based Peritoneal Dialysis Solution Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Glucose-based Peritoneal Dialysis Solution Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Glucose-based Peritoneal Dialysis Solution Sales Value Share by Country, 2025 VS 2032
7 Glucose-based Peritoneal Dialysis Solution Country-level Sales and Value Analysis
  1. 7.1 Global Glucose-based Peritoneal Dialysis Solution Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Glucose-based Peritoneal Dialysis Solution Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Glucose-based Peritoneal Dialysis Solution Sales by Country (2021-2032)
  4. 7.3.1 Global Glucose-based Peritoneal Dialysis Solution Sales by Country (2021-2026)
  5. 7.3.2 Global Glucose-based Peritoneal Dialysis Solution Sales by Country (2027-2032)
  6. 7.4 Global Glucose-based Peritoneal Dialysis Solution Sales Value by Country (2021-2032)
  7. 7.4.1 Global Glucose-based Peritoneal Dialysis Solution Sales Value by Country (2021-2026)
  8. 7.4.2 Global Glucose-based Peritoneal Dialysis Solution Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Glucose-based Peritoneal Dialysis Solution Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Glucose-based Peritoneal Dialysis Solution Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Glucose-based Peritoneal Dialysis Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Baxter
  2. 8.1.1 Baxter Company Information
  3. 8.1.2 Baxter Business Overview
  4. 8.1.3 Baxter Glucose-based Peritoneal Dialysis Solution Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Baxter Glucose-based Peritoneal Dialysis Solution Product Portfolio
  6. 8.1.5 Baxter Recent Developments
  7. 8.2 Fresenius
  8. 8.2.1 Fresenius Company Information
  9. 8.2.2 Fresenius Business Overview
  10. 8.2.3 Fresenius Glucose-based Peritoneal Dialysis Solution Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Fresenius Glucose-based Peritoneal Dialysis Solution Product Portfolio
  12. 8.2.5 Fresenius Recent Developments
  13. 8.3 B. Braun
  14. 8.3.1 B. Braun Company Information
  15. 8.3.2 B. Braun Business Overview
  16. 8.3.3 B. Braun Glucose-based Peritoneal Dialysis Solution Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 B. Braun Glucose-based Peritoneal Dialysis Solution Product Portfolio
  18. 8.3.5 B. Braun Recent Developments
  19. 8.4 WEGO
  20. 8.4.1 WEGO Company Information
  21. 8.4.2 WEGO Business Overview
  22. 8.4.3 WEGO Glucose-based Peritoneal Dialysis Solution Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 WEGO Glucose-based Peritoneal Dialysis Solution Product Portfolio
  24. 8.4.5 WEGO Recent Developments
  25. 8.5 Huaren Pharmaceutical
  26. 8.5.1 Huaren Pharmaceutical Company Information
  27. 8.5.2 Huaren Pharmaceutical Business Overview
  28. 8.5.3 Huaren Pharmaceutical Glucose-based Peritoneal Dialysis Solution Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Huaren Pharmaceutical Glucose-based Peritoneal Dialysis Solution Product Portfolio
  30. 8.5.5 Huaren Pharmaceutical Recent Developments
  31. 8.6 CR Double-Crane
  32. 8.6.1 CR Double-Crane Company Information
  33. 8.6.2 CR Double-Crane Business Overview
  34. 8.6.3 CR Double-Crane Glucose-based Peritoneal Dialysis Solution Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 CR Double-Crane Glucose-based Peritoneal Dialysis Solution Product Portfolio
  36. 8.6.5 CR Double-Crane Recent Developments
  37. 8.7 Qingshan Likang
  38. 8.7.1 Qingshan Likang Company Information
  39. 8.7.2 Qingshan Likang Business Overview
  40. 8.7.3 Qingshan Likang Glucose-based Peritoneal Dialysis Solution Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Qingshan Likang Glucose-based Peritoneal Dialysis Solution Product Portfolio
  42. 8.7.5 Qingshan Likang Recent Developments
  43. 8.8 SSY Group
  44. 8.8.1 SSY Group Company Information
  45. 8.8.2 SSY Group Business Overview
  46. 8.8.3 SSY Group Glucose-based Peritoneal Dialysis Solution Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 SSY Group Glucose-based Peritoneal Dialysis Solution Product Portfolio
  48. 8.8.5 SSY Group Recent Developments
  49. 8.9 Wuhu Daorun Pharmaceuticals
  50. 8.9.1 Wuhu Daorun Pharmaceuticals Company Information
  51. 8.9.2 Wuhu Daorun Pharmaceuticals Business Overview
  52. 8.9.3 Wuhu Daorun Pharmaceuticals Glucose-based Peritoneal Dialysis Solution Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Wuhu Daorun Pharmaceuticals Glucose-based Peritoneal Dialysis Solution Product Portfolio
  54. 8.9.5 Wuhu Daorun Pharmaceuticals Recent Developments
  55. 8.10 Pharmasyntez Group
  56. 8.10.1 Pharmasyntez Group Company Information
  57. 8.10.2 Pharmasyntez Group Business Overview
  58. 8.10.3 Pharmasyntez Group Glucose-based Peritoneal Dialysis Solution Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Pharmasyntez Group Glucose-based Peritoneal Dialysis Solution Product Portfolio
  60. 8.10.5 Pharmasyntez Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glucose-based Peritoneal Dialysis Solution Value Chain Analysis
  2. 9.1.1 Glucose-based Peritoneal Dialysis Solution Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glucose-based Peritoneal Dialysis Solution Sales Mode & Process
  6. 9.2 Glucose-based Peritoneal Dialysis Solution Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glucose-based Peritoneal Dialysis Solution Distributors
  9. 9.2.3 Glucose-based Peritoneal Dialysis Solution Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst